Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDNQ   US24823Q1076

DENDREON CORPORATION (DNDNQ)

22
Delayed Quote. Delayed Nasdaq - 05/22 03:59:53 pm
0.0305 USD   -4.69%
02/20DJValeant Approved to Buy Dendreon Assets for $495 Million
02/20 Drugmaker Valeant close to buying Salix - source
02/12 VALEANT SECURES : Bloomberg
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on DENDREON CORPORATION
05/21 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
04/29 DENDREON : Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results
04/21 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
04/17 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
04/08 DENDREON : Other Events (form 8-K)
03/25 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
03/11 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
03/06 DENDREON : Other Events, Financial Statements and Exhibits (form 8-K)
02/27 DENDREON : Change in Directors or Principal Officers, Other Events, Financial St..
02/23 DENDREON : Completion of Acquisition or Disposition of Assets, Change in Directo..
02/20DJValeant Approved to Buy Dendreon Assets for $495 Million
02/20 Drugmaker Valeant close to buying Salix - source
02/20 DENDREON : Entry into a Material Definitive Agreement, Financial Statements and ..
02/20 VALEANT PHARMACEUTICALS INTL : Announces Expiration Of Bid Deadline In Connectio..
02/19 DENDREON : Announces Expiration of Bid Deadline in Connection with Agreement to ..
02/19 DENDREON : Regulation FD Disclosure (form 8-K)
02/17 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
02/13 VALEANT PHARMACEUTICALS INTL : Schedules Bid Deadline in Connection with Agreeme..
02/12 VALEANT SECURES FINANCING FOR POTENT : Bloomberg
02/11 VALEANT PHARMACEUTICALS INTL : Enters Into Amended Agreement To Remain Lead Bidd..
02/10 VALEANT PHARMACEUTICALS INTL : BRIEF: Valeant wins Dendreon with $400M bid
02/10 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
02/10 DENDREON : Enters into Amended Pact with Valeant
02/06 DENDREON : Entry into a Material Definitive Agreement, Other Events, Financial S..
02/06DJEnergy Future Fights for Control of its Bankruptcy -- Week Ahead
02/04 VALEANT PHARMACEUTICALS INTL : Selected As Lead Bidder To Acquire Dendreon And I..
02/02 DENDREON : Entry into a Material Definitive Agreement, Other Events, Financial S..
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29 Valeant to buy Dendreon's prostate cancer vaccine Provenge
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
01/29 VALEANT PHARMACEUTICALS INTL : BRIEF: Bidder offers $296 million for Dendreon as..
01/27 DENDREON : Regulation FD Disclosure (form 8-K)
01/23 DENDREON : Announces Strong Commercial Start to 2015
01/22 DENDREON : Other Events (form 8-K)
01/22 DENDREON : Results of Operations and Financial Condition, Financial Statements a..
01/22 DENDREON : Cites Strong Commercial Start to 2015
01/21 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
01/19 DENDREON : Cites Strong Commercial Start to 2015
01/15 DENDREON : Announces Strong Commercial Start to 2015
01/12 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2014 DENDREON : heads for auction without $275M minimum bidder
2014 DENDREON : Other Events (form 8-K)
2014 DENDREON : Regulation FD Disclosure, Other Events, Financial Statements and Exhi..
2014 DENDREON : Entry into a Material Definitive Agreement, Change in Directors or Pr..
2014 DENDREON : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or..
2014 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2014 DENDREON CORPORATION : A New Combined Approach to Cancer Immunotherapy is Needed
2014 DENDREON : A New Combined Approach to Cancer Immunotherapy is Needed
2014 DENDREON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
2014 DENDREON : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or..
2014 DENDREON : Seattle's Dendreon files for Ch. 11 bankruptcy protection
2014 DENDREON : Chapter 11 Filing story (Clarification)
2014 DENDREON CORPORATION : Bankruptcies, Breakouts, and Busts; What's Happening in B..
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : S&P 500, Dow Hit Intraday Record Highs
2014DJMARKET SNAPSHOT : U.S. Stocks: S&P 500's Record Highs May Be Put To The Test
2014 DENDREON : Drugmaker Dendreon files for Chapter 11 bankruptcy reorganization
2014 DENDREON : files for Ch. 11 bankruptcy protection
2014 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
2014 DENDREON : Entry into a Material Definitive Agreement, Bankruptcy or Receivershi..
2014 DENDREON : Reaches Agreements on Terms of Financial Restructuring
2014 Feature - As music sales fall, sax player Kenny G turns to stockpicking
2014 DENDREON : sinks after drugmaker warns of debt woes
2014 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
2014 Dendreon Names W. Thomas Amick President and Chief Executive Officer
2014 DENDREON : Elects W. Thomas Amick as President and CEO
2014 DENDREON : Taps W. Thomas Amick President
2014 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
2014 DENDREON : Change in Directors or Principal Officers, Financial Statements and E..
2014 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
2014 DENDREON : Termination of a Material Definitive Agreement (form 8-K)
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDNQ | US24823Q1076 | 4-Traders
Income Statement Evolution
More Financials